Quick Answer
Elevance Health, Inc. reported Net Income of $5.66 billion for fiscal year 2025.
Elevance Health, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $5.66B | -5.3% |
| 2024 | $5.98B | -0.1% |
| 2023 | $5.99B | +1.6% |
| 2022 | $5.89B | -4.3% |
| 2021 | $6.16B | +34.7% |
| 2020 | $4.57B | -4.9% |
| 2019 | $4.81B | +28.2% |
| 2018 | $3.75B | -2.4% |
| 2017 | $3.84B | +55.6% |
| 2016 | $2.47B | -3.5% |
| 2015 | $2.56B | -0.4% |
| 2014 | $2.57B | +3.2% |
| 2013 | $2.49B | -6.2% |
| 2012 | $2.66B | +0.3% |
| 2011 | $2.65B | -8.3% |
| 2010 | $2.89B | -39.2% |
| 2009 | $4.75B | +90.5% |
| 2008 | $2.49B | -25.5% |
| 2007 | $3.35B | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.19B | +17.0% | -31.8% |
| June 30, 2025 | $1.74B | -24.2% | -20.2% |
| March 31, 2025 | $2.18B | -2.8% | +114.9% |
| September 30, 2024 | $1.02B | -21.2% | -55.8% |
| June 30, 2024 | $2.30B | +24.1% | +2.4% |
| March 31, 2024 | $2.25B | +12.9% | +74.2% |
| September 30, 2023 | $1.29B | -19.6% | -30.4% |
| June 30, 2023 | $1.85B | +13.2% | -6.8% |
- Elevance Health, Inc. showed a decrease of -5.3% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, Elevance Health, Inc.’s net income has grown by 69.2% (from $3.35 billion to $5.66 billion).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: